Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin
- 1 February 1986
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 7 (2), 251-269
- https://doi.org/10.1016/s0735-1097(86)80489-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effect of Acetylsalicylic Acid and Dipyridamole on Platelet Survival and Aggregation in Patients with Atherosclerosis ObliteransScandinavian Journal of Haematology, 2009
- Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.JCI Insight, 1985
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- Mechanism of action of dipyridamoleThrombosis Research, 1983
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Factors presaging early recurrent myocardial infarction (“Extension”)The American Journal of Cardiology, 1981
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- DIPYRIDAMOLE AND PLATELET FUNCTIONThe Lancet, 1978
- Effect of dipyridamole and aspirin in thrombotic microangiopathy.BMJ, 1972
- Effect of a Pyrimidopyrimidine Derivative on Thrombus Formation in the RabbitNature, 1965